Viewing Study NCT05509894


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-25 @ 11:57 PM
Study NCT ID: NCT05509894
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-19
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module